Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

Heparin

 

GCEMS Protocol:

 

  • Acute Coronary Syndrome
  • Post Resuscitation

 

INDICATIONS:

 

  • Anticoagulation Therapy

 

DOSAGE:

 

ADULT:

 

  • 5000 units IV/IO
  • OLMC if not alert and unresponsive

 

PEDIATRIC:

 

  • NOT INDICATED

 

CONTRAINDICATIONS:

 

  • Severe thrombocytopenia
  • Uncontrollable active bleeding

 

 SIDE EFFECTS:

 

  • No immediate side effects except hypersensitivity reaction.  Late side effects include minor or major hemorrhage, including intracerebral hemorrhage.